Table 4.

Clinical care during the 2-year follow-up of participants with electronic healthcare record data who were newly diagnosed with COPD by case-finding or usual care

		Diagnostic route
		Case finding (n=344)		Usual care (n=188)
		N*	(%)	N*	(%)
Clinical assessments
MRC dyspnoea score recorded		98	28.5	171	91
CAT score recorded		36	10.5	94	50
Spirometry undertaken		48	14	79	42
COPD severity recorded		33	9.6	96	51.1
BMI recorded		244	70.9	168	89.4
Oxygen saturations recorded		41	11.9	55	29.3
Chest X-ray undertaken		13	3.8	9	4.8
Depression screen undertaken		54	15.7	55	29.3
Clinical interventions
Listed on COPD register		78	22.7	175	93.1
Care plan recorded		38	11	97	51.6
Annual review undertaken		91	26.5	170	90.4
Smoking cessation counselling		157	45.6	139	73.9
Nicotine replacement therapy		27	7.8	17	9
Influenza vaccination provided		240	69.8	138	73.4
Pneumococcal vaccine provided		19	5.6	23	12.2
Pulmonary rehabilitation provided		17	4.9	42	22.3
Inhaler technique assessed		56	16.3	116	61.7
Inhalers prescribed	Salbutamol	128	37.2	152	80.9
	Ipratropium	5	1.5	10	5.3
	Salmeterol	3	0.9	10	5.3
	Fluticasone	3	0.9	1	0.5
	Budesonide	0	0	0	0
	Beclometasone	20	5.8	13	6.9
	Fluticasone/salmeterol	33	9.7	70	37.2
	Budesonide/formoterol	12	3.5	23	12.2
	Any of the above inhalers	134	39	163	86.7
Antibiotic rescue pack		10	2.9	43	22.9
Prednisolone		51	14.8	96	51.1
Clinical care score	<5	225	65.4	17	9
	5–9	83	24.1	73	38.8
	≥10	33	9.6	98	52.1
	Median (IQR)	3	(2–5)	10	(7–12)

*Number of participants who received the clinical assessment or intervention.

BMI, body mass index; CAT, COPD assessment test; COPD, chronic obstructive pulmonary disease; MRC, Medical Research Council.